GI
BCYC

GAMMA Investing’s Bicycle Therapeutics BCYC Stock Holding History

GAMMA Investing’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.7K Buy
7,704
+6,447
+513% +$29.6K ﹤0.01% 2563
2026
Q1 		$5.83K Sell
1,257
-129
-9% -$737 ﹤0.01% 3308
2025
Q4 		$9.81K Sell
1,386
-730
-34% -$5.38K ﹤0.01% 2987
2025
Q3 		$16.4K Buy
2,116
+628
+42% +$4.74K ﹤0.01% 2623
2025
Q2 		$10.3K Buy
1,488
+430
+41% +$3.42K ﹤0.01% 2783
2025
Q1 		$8.98K Buy
1,058
+141
+15% +$1.66K ﹤0.01% 2802
2024
Q4 		$12.8K Sell
917
-1,109
-55% -$23.8K ﹤0.01% 2480
2024
Q3 		$45.8K Buy
2,026
+1,038
+105% +$23.9K ﹤0.01% 1549
2024
Q2 		$20K Buy
988
+117
+13% +$2.64K ﹤0.01% 1854
2024
Q1 		$21.7K Buy
871
+349
+67% +$7.41K ﹤0.01% 1599
2023
Q4 		$9.11K Buy
+522
New +$8.64K ﹤0.01% 1959

Other funds holding BCYC

MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

GAMMA Investing's BCYC Position: Q2 2026 in Review

GAMMA Investing increased its Bicycle Therapeutics (BCYC) stake by 513% in Q2 2026, buying an estimated $29.6K and bringing the position to 7,704 shares worth $32.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2563.

GAMMA Investing first reported a position in BCYC in Q4 2023 and has held it in 11 quarters since. The position peaked at $45.8K in Q3 2024. 6 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • GAMMA Investing held 7,704 shares of Bicycle Therapeutics worth $32.7K as of Q2 2026.
  • GAMMA Investing bought 6,447 Bicycle Therapeutics shares in Q2 2026, an estimated $29.6K.
  • Bicycle Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2563 holding.
  • GAMMA Investing first reported a position in Bicycle Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Bicycle Therapeutics position peaked at $45.8K in Q3 2024.
  • 6 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.